Exploring the Importance of Differential Expression of Autophagy Markers in Term Placentas from Late-Onset Preeclamptic Pregnancies
Authors:
- Luis M. Garcia-PuenteLGLuis M. Garcia-Puente
- Cielo García-MonteroCGCielo García-Montero
- Oscar Fraile-MartinezOFOscar Fraile-Martinez
- Julia BujanJulia Bujan
- Juan A. De León-LuisJuan A. De León-Luis
- Coral BravoCBCoral Bravo
- Patrocinio Rodríguez-BenitezPRPatrocinio Rodríguez-Benitez
- Laura López-GonzálezLLLaura López-González
- Raul Díaz-PedreroRDRaul Díaz-Pedrero
- Melchor Álvarez-MonMÁMelchor Álvarez-Mon
- Natalio García-HonduvillaNatalio García-Honduvilla
- Miguel A. SaezMSMiguel A. Saez
Open Access
- 7 February 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2029
Abstract
Preeclampsia (PE) is a serious hypertensive disorder affecting 4–5% of pregnancies globally, leading to maternal and perinatal morbidity and mortality and reducing life expectancy in surviving women post-gestation. Late-onset PE (LO-PE) is a clinical type of PE diagnosed after 34 weeks of gestation, being less severe than the early-onset PE (EO-PE) variant, although both entities have a notable impact on the placenta. Despite the fact that most studies have focused on EO-PE, LO-PE does not deserve less attention since its prevalence is much higher and little is known about the role of the placenta in this pathology. Via RT-qPCR and immunohistochemistry methods, we measured the gene and protein expressions of several macroautophagy markers in the chorionic villi of placentas from women who underwent LO-PE (n = 68) and compared them to normal pregnancies (n = 43). We observed a markedly distinct expression pattern, noticing a significant drop in NUP62 expression and a considerable rise in the gene and protein expressions of ULK1, ATG9A, LC3, ATG5, STX-17, and LAMP-1 in the placentas of women with LO-PE. A major induction of autophagic processes was found in the placental tissue of patients with LO-PE. Abnormal signaling expression of these molecular patterns in this condition aids in the understanding of the complexity of pathophysiology and proposes biomarkers for the clinical management of these patients.Keywords
Funding Information
- Instituto de Salud Carlos III (Estatal de I + D + I 2020–2027, P2022/BMD-7321)
- European Development Regional Fund (Estatal de I + D + I 2020–2027, P2022/BMD-7321)
- Comunidad de Madrid (Estatal de I + D + I 2020–2027, P2022/BMD-7321)
- ProACapital (Estatal de I + D + I 2020–2027, P2022/BMD-7321)
This publication has 47 references indexed in Scilit:
- Observation of increased levels of autophagy-related genes and proteins in women with preeclampsia: a clinical studyMolecular Biology Reports, 2023
- Increase of autophagy marker p62 in the placenta from pregnant women with preeclampsiaHuman Immunology, 2022
- The Classification and Basic Processes of Autophagy2021
- Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and ChinaJAMA Network Open, 2021
- Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- HDAC4 Knockdown Induces Preeclampsia Cell Autophagy and Apoptosis by miR-29bReproductive Sciences, 2020
- Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2018
- Evaluation and management of severe preeclampsia before 34 weeks' gestationAmerican Journal of Obstetrics and Gynecology, 2011
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- SnapShot: MacroautophagyCell, 2008